Clear, source-aware explanations of peptide terminology, research context, and the claims readers run into online.
Weight Loss
2026-05-23
An investigational once-weekly triple hormone receptor agonist being studied across obesity, type 2 diabetes, and related cardiometabolic conditions.
Fundamentals
Browse the full peptide library by category, evidence context, regulatory notes, and guide status.
Analyze stack overlap, mechanistic fit, evidence tension, and research cautions across available peptides.
Convert vial strength, solvent volume, concentration, and dose units with a focused research math tool.
Research guides
Current comparison, regulatory, and research-literacy guides for readers who want context before digging into individual peptide profiles.
Ozempic CKD A source-backed guide to Ozempic for chronic kidney disease, semaglutide FLOW evidence, type 2 diabetes limits, kidney endpoints, side effects, and product boundaries.
Zepbound heart failure A research-backed guide to tirzepatide and obesity-related HFpEF, SUMMIT evidence, Zepbound label boundaries, side effects, and what heart-failure claims can and cannot say.
Wegovy MASH A research-backed guide to Wegovy for MASH, semaglutide fatty-liver evidence, biopsy endpoints, accelerated approval, side effects, and claim limits.
